A Translational Research Program for the Development of New Strategies for Immunotherapy Against Cancer
Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells
Aug. 7, 2017 1:39 PM
The Malmberg group published in August 2017 an article describing a protocol to generate adaptive natural killer (NK) cells for cell therapy against pediatric acute lymphoblastic leukemia (ALL).
Prestigious grant for JCIT researchers Goodridge and Malmberg
Feb. 13, 2018 8:04 AM
Jodie Goodridge and Karl-Johan Malmberg have received a grant from The Research Council of Norway (RCN) Toppforsk for the project "Programming natural killer cell function through the organelle communication". Their application was among the 16% that was granted.